Histone methylation is critical for the formation and maintenance of long-term memories. Long noncoding RNAs (lncRNAs) are regulators of histone methyltransferases and other chromatin modifying enzymes (CMEs). We investigated how lncRNA Neat1-mediated histone methylation contributes to hippocampusdependent long-term memory formation, using a combination of transcriptomics, RNA binding protein immunoprecipitation, CRISPR mediated gene activation, and behavioral approaches. Suppression of the lncRNA Neat1 revealed widespread changes in gene transcription as well as perturbations of histone 3 lysine 9 dimethylation (H3K9me2), a repressive histone modification mark that is dysregulated in the aging hippocampus. We identified a Neat1-dependent mechanism of transcriptional repression via H3K9me2 at the c-Fos promoter corresponding with observed changes in c-Fos mRNA levels. Overexpression of hippocampal Neat1 via CRISPRa is sufficient to impair memory formation in young adults, recapitulating observed memory deficits in old adults, while Neat1 suppression in both young and old adult mice improves memory. These results suggest that lncRNA Neat1 is a potent epigenetic regulator of hippocampus-dependent long-term memory formation.
INTRODUCTION
While recent efforts have characterized thousands of lncRNAs in the human and mammalian genome, few lncRNAs are as wellstudied, as the human Nuclear-Enriched Abundant Transcript 1 (NEAT1). NEAT1 is evolutionarily conserved between rodents and humans, particularly within the 5' region of the transcript 1 . Multiple isoforms of NEAT1 exist in rodents and in humans, with the longer of the major isoforms proving essential for phase separation and induction of nuclear paraspeckle assembly 2, 3 , while the shorter NEAT1 transcripts do not appear to be a major regulator of paraspeckle formation 4 . Recent studies have characterized a number of molecular pathways by which NEAT1 regulates the epigenome, including both paraspeckle-dependent sequestration of transcription factors, as well as paraspeckle-independent roles for NEAT1 in transcriptional regulation via scaffolding of CMEs [5] [6] [7] . Additionally, NEAT1 itself has been observed to bind numerous genomic loci and to effect regulation of transcription 8, 9 .
Research on the human NEAT1 has been largely focused on its role as an oncogene in various cancers (as reviewed previously 10 ), which occurs largely through its regulation of epigenetic mechanisms. However, the rodent homolog Neat1 is also upregulated in the hippocampus of aging mice 11 and has recently been linked to multiple cognitive and n e u r o d e g e n e r a t i v e d i s o r d e r s , i n c l u d i n g schizophrenia 12 , Huntington's Disease 13 , Parkinson's Disease 14, 15 , Alzheimer's Disease 16 , and epilepsy 17, 18 . Furthermore, recent evidence suggests that Neat1 may play a role in neuroplasticity 17 ; however, despite such extensive health relevance, the role of Neat1 in epigenetic regulation of genes within hippocampal neurons, particularly during long-term memory formation. We used RNA-sequencing, CRISPR mediated gene activation (CRISPRa), and memory tests to investigate the functional role of lncRNA Neat1 in gene expression dynamics and the role that age-related changes in Neat1 expression might play in memory deficits in older adults.
NEAT1 supports this observation, as CNS tissues segregate cleanly when sorted based on NEAT1 transcript expression (Fig. 1D, Supplemental Figs. 
1A-B).
Examination of single-cell RNA-seq data from resected human CNS tissue and glioblastoma 22 further suggests that expression of NEAT1 within CNS cells is restricted in neurons, while other cell types including astrocytes, oligodendrocytes, and vascular cells express NEAT1 at higher levels. . This is in contrast to the neighboring lncRNA transcript MALAT1 which appears to be ubiquitously expressed at high levels in all CNS cell types (Supplemental Fig. 1E ). Given the growing body of literature that has noted overexpression of NEAT1 in the aging brain 23, 24 , as well as the established role of NEAT1 as a regulator of epigenetic mechanisms, and the recentlydescribed role of NEAT1 in cognitive disorders such as schizophrenia 12 , we sought to further investigate the role of the lncRNA NEAT1 on the neuroepigenetic mechanisms of cognition.
NEAT1 regulates the immediate early gene c-Fos involved in synaptic plasticity
To investigate the role of NEAT1 at the transcriptomic level, we analyzed a publicly available RNA-seq dataset from iPSC-derived human neurons. Antisense oligo (ASO) knockdown of NEAT1 in KCltreated human neurons revealed an extensive cohort of differentially expressed mRNAs. Knockdown alone was not sufficient to perturb the transcriptome in resting iPSC-derived human neurons, as evidenced by an imperfect separation via unsupervised hierarchical clustering prior to KCl stimulation ( Fig.  2A) . In contrast, NEAT1-knockdown appears to dramatically potentiate KCl-driven differential expression of many genes ( Fig. 2A-B ).
To gain some insight into the health relevance for observed NEAT1-mediated changes in gene expression in human neurons, we queried the annotated disease classes from the Genetic Association Database via the Database for Annotation, Visualization and Integrated Discovery (DAVID) 25 , and observed significant enrichment for three disease classes: cancer, renal, and aging. (Supplemental File 2). NEAT1-regulated genes appear to be non-randomly distributed among annotated biological processes (Fig. 2C ), molecular functions (Supplemental File 2) and cellular components (Fig. 2D ). Significant gene ontology (GO) term enrichment was partially consistent with previous observations of the NEAT1 regulatory axis, as we observed significant regulation of GO terms associated with viral gene expression; however, we also observed significant enrichment of GO terms important for hippocampal function, including the transcription factor AP-1 complex (GO:0035976, Fig.  2C-D) .
The human Fos proto-oncogene (FOS, also known as C-FOS), a critical component of the AP-1 transcription factor subunit appeared to be overexpressed in human neurons after knocking down NEAT1 both in quiescent and KCl-stimulated n e u r o n s a n d h a s a k n o w n r e l e v a n c e f o r hippocampus-dependent memory formation 26 (Figs. 2E-F). Thus, we selected the murine homolog c-Fos as a candidate gene for further studies of Neat1's regulatory potential.
Neat1 is regulated by neuronal excitability and controls c-Fos gene expression
As modeling Neat1 expression changes in response to in vivo neuronal activity and behavioral experience required the mammalian model organisms, we next sought to examine the regulatory capacity of Neat1 in rodent neurons. For this purpose, we knocked down murine Neat1 in the mouse Neuro-2a (N2a) cell line using small interfering RNAs (siRNAs). We observed that 24h after treatment with Neat1-targeting siRNAs (Fig.  3A) , expression of the c-Fos mRNA was significantly upregulated (Fig. 3B) .
Interestingly, while our observations of c-Fos transcript expression in murine neurons recapitulated observations from human neurons, we observed that expression of the immediate early genes Egr1 and B t g 2 w e r e n o t o v e r e x p r e s s e d i n m o u s e (Supplemental Fig. 2A -B) as they were in human neurons (Supplemental File 2), suggesting that there are species-specific regulatory differences in the Neat1 regulatory axis.
As mice with the c-Fos gene knocked out in the CNS show a specific loss of hippocampus-dependent spatial and associative learning tasks 26 , we next sought to investigate the relevance of Neat1 expression during memory consolidation after a hippocampus-dependent learning task. One hour after training in contextual fear conditioning we observed a significant reduction in the expression of Neat1 in the dorsal hippocampus coinciding with previously reported increases in expression of the cFos mRNA (Figs. 3C-D) . As baseline expression of Neat1 in neurons is expected to be quite restricted compared to other cell types, we next stimulated neurons with KCl to ascertain the effect of activity on the expression of Neat1. Consistent with recent reports 17 , we observed that KCl stimulation drives a rapid reduction in Neat1 expression in both N2a cells ( Supplementary Fig. 2E ) and primary hippocampal pyramidal neurons, as recently reported (Figs. 3E-F), and consistent with the effects of context fear conditioning in vivo.
Neat1 regulates H3K9me2 globally and controls cFos promoter H3K9me2 and gene expression
We next sought to investigate the c-Fos-relevant mechanisms of Neat1-orchestrated transcriptional control.
To accomplish this, we used publicly available data assaying Neat1 chromatin binding via capture hybridization analysis of RNA targets and high-throughput sequencing (CHART-seq) in human MCF7 cells 8 . After mapping Neat1-bound peaks to the nearest transcription start sites, we observed that only a small subset of genes directly bound by Neat1 are differentially expressed either after Neat1 knockdown or in the context of neuronal activation. However, we observed significant enrichment of Neat1 binding near genes associated with histone As c-Fos has previously been observed to be regulated by the Ehmt1/2 complex in the context of hippocampus-dependent memory formation 27 , we next sought to investigate the role of Neat1 in the regulation of histone methylation and H3K9me2 specifically. After knockdown of Neat1 in neuronal cells, we observed that H3K9me2 is reduced at a global scale while the expression of other histone modifications are unchanged ( Fig. 4C-F) . To ascertain whether the lncRNA Neat1 physically associates with the H3K9me2 methyltransferase complex in neurons, w e p e r f o r m e d R N A b i n d i n g p r o t e i n immunoprecipitations against the Ehmt2 subunit of the obligatory Ehmt1/2 heterodimer [27] [28] [29] . Consistent with recently published results 6 , we observed interaction between Neat1 and the H3K9me2 methyltransferase Ehmt2, suggesting multiple possible modes of action for Neat1-mediated regulation of H3K9me2.
To assess the functional relevance of the Neat1-H3K9me2 regulatory axis on the expression of c-Fos mRNA, we performed ChIP in conjunction with qPCR at the c-Fos promoter. We observed that after Neat1 knockdown with siRNAs, H3K9me2 at the c-Fos promoter was significantly depleted (Fig. 4G) , consistent with observed changes in gene expression (Fig. 3B) , while H3K9me2 within the c-Fos gene body were not significantly changed ( Supplementary Fig.  2F ).
Neat1 knockdown regulates hippocampal memory formation and the epigenetic landscape at the c-Fos promoter in vivo
Having demonstrated that Neat1 represses the epigenetic landscape and neuronal expression of the memory-critical c-Fos gene, we next sought to investigate the functional role of Neat1 expression on c-Fos promoter methylation and memory formation in vivo.
To ask whether Neat1 expression impacts hippocampus-dependent memory formation, we knocked down expression of Neat1 in hippocampal area CA1 by directly infusing Neat1-targeting siRNAs or non-targeted siRNAs and assayed long term memory function using contextual fear conditioning, a hippocampus-dependent memory task (Fig. 5A) . We observed that five days after intra-CA1 injection of Neat1-targeting siRNAs, a time when we observe significant reduction in expression of Neat1 (Supplemental Fig. 3A ), mice had no differences in freezing behavior during the training phase of contextual fear conditioning, either before or after delivery of the foot shock (Fig. 5B) . However, when returned to the training context 24h later, mice that received Neat1-targeting siRNAs displayed significant increases in freezing behavior relative to mice that received nontargeting siRNAs (Fig. 5C ).
To determine whether Neat1 expression impacts c-Fos promoter methylation in vivo, we sacrificed an additional cohort of behaviorally naïve animals five days after injection of siRNAs and performed ChIP-qPCR assays on one hemisphere of dorsal CA1 tissue collected from around the injection site. Consistent with our results in cultured neurons (Fig. 4G) , we observed that concurrently with Neat1 knockdown five days after infusion with siRNAs, Neat1 knockdown significantly reduced H3K9me2 at the c-Fos promoter in dorsal area CA1 (Fig. 5E ). Thus, we hypothesized a model in which Neat1 expression might be regulating memory formation via epigenetic repression of cFos.
Mimicking age-related upregulation of Neat1 is sufficient to respectively restore or impair hippocampus-dependent memory formation Numerous studies have reported overexpression of Neat1 in senescing cells, as well as in aging CNS tissues in both humans and mice 11, 30 . Upon comparing publicly available hippocampus RNA-seq datasets from 3 month-old young mice versus 24 month-old aged mice we observed upregulation of Neat1 relative to young animals, consistent with (Fig. 6A) , as well as downregulation of c-Fos gene expression (Fig. 6B) , consistent with previously reported age-associated hippocampus-dependent memory impairments 11 .
We next tested whether hippocampus-dependent memory formation might be improved in aged mice by knockdown of Neat1. To this end, we knocked down expression of Neat1 in the hippocampal area CA1 of 18-19 month-old mice, an age at which we have previously observed significant upregulation of H3K9me2 in the aging rat hippocampus 31 (Supplemental Fig. 4) , by directly infusing Neat1-targeting siRNAs or non-targeted siRNAs and assayed long term memory function using contextual fear conditioning, with three pairings of the shock to the novel context (Fig. 6C) . We observed that knockdown of Neat1 in the dorsal hippocampus of aged mice resulted in significant improvements in freezing after 24h (Figs. 6D-E) , but not during training, similar to results seen in young mice (Fig.  5C ).
We next sought to test the sufficiency of Neat1 overexpression to regulate performance in memory tasks, we designed a single guide RNA (sgRNA) targeting Neat1 for overexpression from the endogenous locus (Fig. 7A, Supplemental Fig. 3B-C) , and delivered the CRISPRa system in vivo into dorsal CA1 via in vivo transfection (Fig. 7B ). Mice were then trained in contextual fear conditioning with three pairings of the shock to the novel context (Fig. 6D) . Animals overexpressing Neat1 from the endogenous locus (Neat1-OE) had no significant differences in freezing during the training period, either before or after exposure to the unconditioned stimulus (Fig.  6E) ; however, when returned to the training context 24 h after training, Neat1-OE animals froze significantly less than control animals which received only the sgRNA plasmid (Fig. 6F) , suggesting that elevated Neat1 in area CA1 is sufficient to impair hippocampus-dependent memory formation.
DISCUSSION
While previous studies have observed regulatory roles for the lncRNA NEAT1, including that NEAT1 localizes to chromatin and governs chromatin modification 8, 9 , little work has been done to resolve this regulatory role of NEAT1 in the context of longterm memory formation. RNA sequencing analysis revealed that the human lncRNA NEAT1 binds to the EHMT1 locus and that NEAT1 knockdown regulates neuronal EHMT1 expression (Supplemental Data S1). We observed that murine Neat1 acts as a potent regulator of H3K9me2 both in cultured cells and in vivo (see Fig. 4 ). Due to recent observations that NEAT1 interacts directly with Ehmt2 6 , an observation which we ourselves have reproduced via RIP (see F i g . 4 ) , w e c a n n o t y e t a s c e r t a i n w h e t h e r transcriptional control of EHMT1 or direct interaction with the repressor complex is the rate-limiting factor for H3K9me2 abundance. This intricate multipoint interaction is perhaps illustrative of the intricate systems of regulatory feedback which are thought to control epigenetic mechanisms. Nonetheless, knockdown of Neat1 was sufficient to perturb this system and to result in both bulk and site-specific changes in H3K9me2 in neurons.
Previous investigations as to the epigenetic regulatory role of Neat1 have resulted in paradoxical observations to the effect that Neat1 binds to genomic loci and mediates activation of transcription 9 , but that suppression of Neat1 expression results primarily in increased neuronal gene expression 17 . We show here that Neat1 induces widespread regulation of neuronal H3K9me2, potentially resolving this dilemma and further explaining age-related increases in H3K9me2 previously observed in the hippocampus. Moreover, we observed that Neat1 expression is correlated with H3K9me2 globally as well as at the promoter of the aging-repressed memory-related gene c-Fos. While Neat1 has been observed to act on and via numerous epigenetic mechanisms, to our knowledge this is the first observation that Neat1-mediated epigenetic mechanisms are sufficient to govern cognitive function.
Studies of the neuronal impact of Neat1 expression have thus far been limited to the context of neurological disorders, and in many c a s e s t o c u l t u r e d n e u r o n a l c e l l s . O u r observations suggest that
Neat1 plays a regulatory role in neuronal H3K9me2 both in cultured neurons and in vivo, and that increases in Neat1 might play a significant role in the agerelated decline of hippocampus-dependent memory formation. In humans, expression of NEAT1 is generally limited in the CNS, and overexpression is a common hallmark of several neurological disorders. While experimental reduction of Neat1 has very recently been shown to have therapeutic potential in the context of such disorders, the impact of age-related changes in expression has remained unexplored until now. Interestingly, while our experiments were designed to investigate the age-related impact of Neat1, we note that recent experiments have described neuroinflammation-mediated increases in Neat1 expression 32 , and that the findings described in this manuscript implicate Neat1 as a potential mechanism by which neuroinflammation might impact memory.
While the experiments described here are largely sufficient to explain prior observations of elevated H3K9me2 in the aging hippocampus (Supplementary Fig. 4 ; 31 , our experiments indicate that increased expression of Neat1 is not sufficient to explain all of the aging-related neuroepigenetic changes observed in this region. It is likely that many hippocampal lncRNAs have distinct or overlapping roles in the regulation of the neuroepigenetic aging process. Indeed, human NEAT1 itself has been observed to associate with multiple chromatin modifying enzymes 6, [33] [34] [35] . Although we did not detect significant regulation of histone modifications other than H3K9me2 at the global level after knockdown of Neat1, the absence of such observations does not preclude the existence of biologically or behaviorally meaningful epigenetic Figure 6 . Neat1-knockdown improves long-term memory in aged animals (A-B) DESeq2-generated normalized counts of RNAseq data from 3mo and 24mo C57/B6 mice. Neat1 expression (A) was significantly elevated and c-Fos mRNA (B) was significantly repressed in aged hippocampi relative to the hippocampi of young mice. (C) Graphic depiction of siRNA infusion into hippocampal area CA1 and single-pairing contextual fear conditioning paradigm. Briefly, 18mo old male C57/ B6 mice were trained 5d after bilateral infusion of siRNAs and tested 24h after training. (D-E). Aged mice (18 month-old) were trained with three pairings of shock with a novel context after knockdown of Neat1 and demonstrated no significant difference during training (D) (n = 7,9; p = 0.2496), but significantly enhanced freezing 24h after testing (E) (n = 7,9; p = 0.0039).
regulation that is more limited in scope and might be uncovered in future studies with a large-scale sequencing approach. In this work, we demonstrate that Neat1 regulates a critical transcriptional pathway for hippocampusdependent memory in rodent neurons in vitro, in vivo, and likewise in iPSC-derived human neurons. While attempts to establish the functionality of the evolutionarily conserved lncRNA Neat1 have met with limited success, little has yet been done to functionally characterize Neat1 in the context of cognition. Here, we observed that the lncRNA Neat1 may serve as an endogenous molecular brake on the formation of hippocampus-dependent spatial memories. 
METHODS
Animal housing. Naïve 3-7 month-old or 18 month-old C57BL/6 mice were group housed (2-7 animals/cage) in plastic cages with ad libitum access to food and water and were maintained on a 12-h light/dark cycle. All behavioral tests were conducted during the light cycle, and all procedures were approved by the University of Alabama at Birmingham Institutional Animal Care and Use Committee and done in accordance with the National Institute of Health ethical guidelines.
Cell culture. N2A cells were maintained in DMEM supplemented with 10% FBS. After thawing, the cells were passaged a minimum of two times prior to use in experiments. The cells were kept at 37℃ in a 5% CO2 incubator. Dissociated cultures of hippocampal pyramidal cells were obtained from embryonic day 18 rat embryos as described previously 36 . Briefly, timed-pregnancy female Sprague-Dawley rats were terminally anesthetized and embryos were removed from the uterus, then transferred to Hank's balanced salt solution (HBSS, Gibco) for dissection. Primary rat hippocampal neurons were dissociated via incubation with papain for 20 min at 37°C, rinsed in HBSS, then resuspended in Neurobasal medium (Gibco) and further mechanically dissociated by passing through a series of progressively smaller fire-polished glass Pasteur pipettes. The resulting suspension was passed through a 70-µm cell strainer and plated on poly-L-lysine coated 24-well plates (~7.5x10 4 cells per well). Cells were maintained for 2 weeks in Neurobasal supplemented with B-27 and Glutamax (Thermo Fisher Scientific) at 37°C and 5% CO2. For KCl stimulation, 6.25μL 1M KCl (Sigma) was added to two-week in vitro cultures, for a final concentration of 12.5mM KCl.
siRNA Delivery. Young, 3-7 month-old mice were anesthetized with an intraperitoneal injection of ketaminedexmedetomidine and received bilateral intra-CA1 injections of Lincode SMARTpool siRNAs (Dharmacon) targeting the murine Neat1 (#R-160022-00-0005) or a negative control (#D-001320-10-05), conjugated with in vivo JetPEI (PolyPlus Transfection), an in vivo transfection reagent, at the stereotaxic coordinates (AP -2.0mm, ML ±1.5 mm, DV−1.7 mm) with respect to bregma. Aliquots of siRNA stocks (100μM) were diluted to a concentration of ~2.5μM and conjugated with in vivo JetPEI on the day of surgery. Infusions were given over a 10 min period (0.1μL per min) for a total volume of 1μL per hemisphere. After a 48 h recovery period, mice were handled daily for >3min and trained in contextual fear conditioning at five days post-surgery. Aged (18-19 month old) mice were treated similarly but were anesthetized with vaporized isoflurane (3% induction, 2% maintenance). Mice were sacrificed at ten days post-surgery and dorsal area CA1 was harvested from each hemisphere.
CRISPRa Delivery. Mice were anesthetized with an intraperitoneal injection of ketamine-dexmedetomidine and received bilateral intra-CA1 injections of a guide RNA expression vector driven by the murine U6 promoter and targeting the murine Neat1 promoter region (Addgene #44248) either alone or in conjunction with an expression vector coding for the S. pyogenes dCas9 fused to two copies of the VP64 transactivator domain (Addgene #59791). Endotoxin-free plasmids were purified using an endotoxin-free plasmid DNA purification kit (Machery-Nagel) and aliquoted to minimize freeze-thaw cycles. Endotoxin-free plasmid stocks were diluted to a final concentration of ~500ng/uL in sterile 10% glucose and incubated with in vivo JetPEI for 15 min at room temperature on the day of surgery. The resulting transfection complex was delivered via direct infusion at the stereotaxic coordinates (AP -2.0mm, ML ±1.5 mm, DV−1.4 mm) with respect to bregma. Infusions were given over a 10 min period (0.1μL per min) for a total volume of 1μL (~500ng plasmid DNA) per hemisphere.
Contextual fear conditioning.
Mice were trained to either a weak or strong contextual fear conditioning (CFC) paradigm in a novel context, and long term memory was assessed upon returning the animals to the training context 24h after training. The weak CFC paradigm consisted of a 118s baseline followed by a single shock (0.5mA, 2 sec) pairing in the novel context, while the strong CFC paradigm consisted of a 119-sec baseline followed by three shock pairings (0.5mA, 1s) with interleaved rest periods of 59 sec each. Twenty-four h after training, animals were placed back into the training context for five min to test retention. Freezing behavior was scored by Med Associates software.
Collection of whole area CA1. One hour after training, the whole brain was removed by gross dissection and placed in oxygenated (95%/5% O2/CO2) ice-cold cutting solution (110mM sucrose, 60mM NaCl, 3mM KCl, 1.25mM NaH2PO4, 28mM NaHCO3, 0.5mM CaCl2, 7mM MgCl2, 5mM glucose, and 0.6mM ascorbate). The CA1 region of the hippocampus was then microdissected from each hemisphere and flash frozen on dry ice.
Collection of dorsal area CA1. Animals were sacrificed by cervical dislocation after overdosing with isoflurane at experiment-specific time points, and the whole brain was rapidly removed and immediately frozen on dry ice. The CA1 region of the dorsal hippocampus was then dissected out with the aid of a mouse brain matrix (Harvard Apparatus) to collect the area of CA1 targeted by siRNA or CRISPRa infusions. All tissue was stored at -80°C prior to processing.
Western blotting. Normalized proteins (2-10µg) were separated via electrophoresis on either 10% or 20% polyacrylamide gels, transferred onto an Immobilon-FL membrane using a turbo transfer system (Biorad). Membranes were blocked in Licor blocking buffer and probed with the following primary antibodies for histone H3 (1:1000; Abcam #ab1791), H3K9me2 (1:1000; Millipore #07-441), H3K27me3 (1:1000; Millipore #07-449), H3K4me3 (1:1000; Millipore #04-745).
Secondary goat anti-rabbit 700CW antibody (1:20,000; Licor Biosciences) was used for detection of proteins using the Licor Odyssey system. All protein quantification was done using ImageStudio Lite software (Licor).
Reverse transcription qPCR (RT-qPCR)
. Section text RNA was extracted from isolated CA1 or cultured cells using Trizol reagent according to the manufacturer's recommended protocol (Fisher).
RNA yield was quantified spectrophotometrically (Nanodrop 2000c), and ~200ng of RNA was DNAse treated (Amplification grade DNAse I, Sigma), converted to cDNA (iScript cDNA synthesis kit; Biorad), and PCR amplified on the CFX1000 real-time PCR system (BioRad), with primer annealing temperatures of 60°C. See supplemental table for full descriptions of primers used. All data were analyzed using the delta delta Ct method.
Cell culture. ChIP was performed as described previously 31, 37 . Briefly, samples were fixed in PBS with 1% formaldehyde for ten minutes at room temperature, chromatin was sheared using a Bioruptor XL on high power, lysates cleared by centrifugation and diluted in TE and RIPA buffer. Extracts were mixed with MagnaChIP protein A/G beads and immunoprecipitations were carried out at 4°C overnight with 5µg primary antibody (anti-H, Abcam #ab40542; anti-Ezh2, #ab3748) or no antibody (control). Immune complexes were sequentially washed with low salt buffer (20 mM Tris, pH 8.0, 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl), high salt buffer (20 mM Tris, pH 8.1, 0.1% SDS, 1% Triton X-100, 500 mM NaCl, 1 mM EDTA), LiCl immune complex buffer (0.25 M LiCl, 10 mM Tris, pH 8.1, 1% deoxycholic acid, 1% IGEPAL-CA630, 500 mM NaCl, 2 mM EDTA), and TE buffer, and eluted into 1xTE containing 1% SDS. Protein-DNA crosslinks were reversed by heating at 65°C overnight. After proteinase K digestion (100µg; 2h at 37°C), DNA was purified by phenol/chloroform/isoamyl alcohol extraction and ethanol precipitation.
Immunoprecipitated DNA was quantified via spectrophotometry (Nanodrop 2000c) and ~15ng of DNA from each sample was assayed via quantitative real-time PCR using primers specific to mouse genes of interest. See supplemental table for full descriptions of primers used.
RNA binding protein immunoprecipitation (RIP)
. RIP was performed as described previously 38 . Briefly, ~5ug of primary antibody against Ehmt2 (Abcam #ab40542), Ezh2(Abcam #ab3748) or normal rabbit IgG (Cell signaling) were conjugated with 25uL MagnaChIP protein A/G beads (EMD Millipore). Freshly harvested nuclear pellets from at least 10^6 N2a cells were sheared via Dounce homogenization (15-20 strokes) in RIP buffer (150 mM KCl, 25 mM Tris pH 7.4, 5 mM EDTA, 0.5 mM DTT, 0.5% NP40, 1x Protease Inhibitor Cocktail (Sigma), 100 U/ml SUPERASin (Ambion), cleared via centrifugation at 13,000 RPM to remove nuclear membrane and debris, and split into fractions for IP. Sheared nuclear extracts were mixed with antibody conjugated MagnaChIP protein A/G beads and immunoprecipitations were carried out at 4°C for four hours. Beads were then immobilized on a magnetic tube rack, and immune complexes were sequentially washed three times with RIP buffer. Beads were then resuspended in 1mL of Trizol (Thermo Fisher), and coprecipitated RNAs were isolated according to the manufacturer's recommended protocol. RT-qPCR for Neat1 was then performed as described above.
Statistical analyses.
Data from all experiments were analyzed using Analysis of Variance (ANOVA) with Fisher LSD post hoc test or with Student's t-test unless otherwise noted in the figure legend. Values reported in the text and error bars are the mean ± SEM unless otherwise noted. All datasets were screened for outliers prior to analysis via Grubb's test (α=0.05) and outliers were subsequently excluded. Statistical tests were performed in R or Prism 7 (GraphPad). Nonparametric tests were used where appropriate and tests were 2-tailed unless otherwise noted. For all experiments, n indicates the number of biological replicates. For cell Supplemental Figure 1. NEAT1 expression is uniquely reduced in the human CNS, and 
